1Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom.
2The University of Manchester Faculty of Biology Medicine and Health, Manchester Academic Health Centre, Manchester, United Kingdom.
Am J Trop Med Hyg. 2021 Mar 8;104(5):1841-1850. doi: 10.4269/ajtmh.20-1433.
Schistosomiasis is a major public health problem in Madagascar. The WHO recommends preventive chemotherapy by mass drug administration (MDA) with praziquantel as the primary approach to control Schistosoma mansoni-related morbidity in endemic populations, alongside complementary interventions such as health education. The impact of annual MDA and health education programs was assessed in the hard-to-reach Marolambo district of eastern Madagascar, an area endemic for S. mansoni. Repeated cross-sectional studies undertaken 2015-2019 examined between 300 and 381 school-aged children (aged 5-14 years) annually. The prevalence and infection intensity of S. mansoni were assessed by urine-circulating cathodic antigen (CCA) dipsticks and coproscopy using Kato-Katz (KK) methodologies. After four rounds of annual MDA, a reduction in S. mansoni prevalence was seen in CCA (93.9% in year 1-87.7% in year 5; P = 0.007) and KK (73.9% in year 1-59.4% in year 5; P < 0.0001). The prevalence of heavy-intensity infections roughly halved from 23.7% to 10.1% (P < 0.0001), and the mean intensity of infection fell by 55.0% (480.2-216.3 eggs per gram of feces). A malacological survey found Biomphalaria pfeifferi snail intermediate hosts in multiple water contact sites including rice paddies, streams, and Nosivolo River. Despite reductions in infection prevalence and intensity, schistosomiasis still poses a significant public health challenge in Marolambo district. Twice yearly MDA cycles and/or community-wide MDA are suggested to better reduce infections. Expanding health education, improving standards of water, sanitation and hygiene, and attention on snail-related control will also be important, especially in rice paddy irrigated areas.
曼氏血吸虫病是马达加斯加的一个主要公共卫生问题。世界卫生组织(WHO)建议采用群体药物治疗(MDA)进行预防性化疗,以吡喹酮作为控制流行地区曼氏血吸虫病相关发病率的主要方法,同时辅以健康教育等补充干预措施。在马达加斯加东部难以到达的马罗拉博地区,对每年进行 MDA 和健康教育计划的效果进行了评估,该地区为曼氏血吸虫病流行区。2015-2019 年期间,采用重复横断面研究方法,每年检查 300 至 381 名学龄儿童(5-14 岁)。采用尿液循环阴极抗原(CCA)试纸条和加藤氏厚涂片法(KK)检测曼氏血吸虫病的流行率和感染强度。经过四轮年度 MDA,CCA(第 1 年为 93.9%-第 5 年为 87.7%;P = 0.007)和 KK(第 1 年为 73.9%-第 5 年为 59.4%;P < 0.0001)检测的曼氏血吸虫病流行率均有所下降。高强度感染的流行率从 23.7%降至 10.1%(P < 0.0001),感染强度平均下降了 55.0%(480.2-216.3 个粪便虫卵/克)。在多个水接触点(包括稻田、溪流和 Nosivolo 河)发现了中间宿主 B. pfeifferi 蜗牛。尽管感染的流行率和强度有所降低,但曼氏血吸虫病在马罗拉博地区仍构成重大公共卫生挑战。建议每年进行两次 MDA 循环和/或全民 MDA,以更好地减少感染。扩大健康教育、改善水、环境卫生标准以及关注与蜗牛相关的控制也将非常重要,特别是在稻田灌溉地区。